Patient Controlled Remifentanil Analgesia for Normal Labour

Mansoura University

Status and phase: Withdrawn; Phase 2

Conditions: Labor Pain; Full Term Pregnancy

Treatments: Drug: Patient-controlled remifentanil analgesia; Drug: Epidural analgesia

Study type: Interventional

Funder types: Other

Identifiers

NCT04541719

MFM-XYZ-2017

Details and patient eligibility

About

Patient controlled remifentanil analgesia might offer comparative overall patient satisfaction and improved quality of analgesia after normal labour with continuous epidural analgesia.

Full description

We are aiming to study the effects of patient controlled remifentanil analgesia and epidural analgesia for normal labour in full term parturients on:

• Peripartum analgesia
• Overall patient's satisfaction
• Maternal adverse effects
• Neonatal outcomes

Sex: Female

Ages: 18 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Gestational age > 36 weeks
• American Society of Anesthesiologists physical class I to III

Exclusion criteria

• Allergy to study solution
• Contraindications to epidural analgesia
• Non consented parturients
• Communications barriers.
• Intrauterine foetal growth retardation
• Foetal distress

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

0 participants in 2 patient groups, including a placebo group

Patient-controlled remifentanil analgesia

Active Comparator group

Description:

Patients will received Patient-controlled remifentanil analgesia starting from labour pain until delivery

Treatment:

Drug: Patient-controlled remifentanil analgesia

Epidural analgesia

Placebo Comparator group

Description:

Patients will received continuous epidural analgesia starting from labour pain until delivery

Treatment:

Drug: Epidural analgesia